s21-editor

Abstract Background The role of radiation therapy (RT) following breast-conserving surgery (BCS) in ductal carcinoma in situ (DCIS) remains controversial. Trials have not identified a low-risk cohort, based on clinicopathologic features, who do not benefit from RT. A biosignature (DCISionRT®) that evaluates recurrence risk has been developed and validated. We evaluated the impact of DCISionRT […]

Abstract Purpose With reports of CNS toxicity in patients treated with proton therapy at doses lower than would be expected based on photon data, it has been proposed that heavy monitor unit (MU) weighting of pencil beam scanning (PBS) proton therapy spots may potentially increase the risk of toxicity. We evaluated the impact of maximum

Abstract Purpose Health care practices across the United States have been consolidating in response to various market forces. The degree of practice consolidation varies widely across specialties but has not been well studied within radiation oncology. This study used Medicare data to characterize the extent of practice consolidation among radiation oncologists and to investigate associated

Abstract Introduction Distant metastases (DMs) are the primary driver of mortality for patients with early stage NSCLC receiving stereotactic body radiation therapy (SBRT), yet patient-level risk is difficult to predict. We developed and validated a model to predict individualized risk of DM in this population. Methods We used a multi-institutional database of 1280 patients with

For Dr. Kristofer Roberts, joining Radiation Oncology Associates (ROA) at Concord Hospital Payson Center for Cancer Care…

For Dr. Kristofer Roberts, joining Radiation Oncology Associates (ROA) at Concord Hospital Payson Center for Cancer Care…

For Dr. Kristofer Roberts, joining Radiation Oncology Associates (ROA) at Concord Hospital Payson Center for Cancer Care…